A researcher at Tufts University has retracted a paper in Cell, a year after retracting a study on a similar subject from the Journal of Biological Chemistry.
Although most of what Alanis Morissette sang about in her hit song “Ironic” wasn’t irony at all, had she included a line or two about Angela Adrian she would have nailed it.
Adrian is an expert in intellectual property law, a former editor of the International Journal of Intellectual Property Management, a legal scholar whose resume boasts more degrees than a protractor. According to this bio:
Dr Angela Adrian is a dual qualified lawyer in Louisiana and the UK. Her specialisms include Intellectual Property, Information Technology, International Trade, and Criminal Law. She has two Masters degrees with distinction in Business & Management (Schiller International University) as well as in Commercial Law (University of Aberdeen). She obtained her Juris Doctorate at Loyola University, New Orleans. Dr Adrian published her PhD from Queen Mary, University of London as a monograph entitled “Law and Order in Virtual Worlds: Exploring Avatars, their Ownership and Rights”. Currently, she is Chief Knowledge Officer of Icondia Ltd, an images rights company, co-author of the 4th edition of “Intellectual Property: Text and Essential Cases” (Australia), and Editor of the International Journal of Intellectual Property Management.
The paper, titled “Hydrogen production by an anaerobic photocatalytic reforming using palladium nanoparticle on boron and nitrogen doped TiO2 catalysts,” was written by researchers from the Veltech Dr RR & Dr SR Technical University, in Chennai, India, and Arizona State University.
A paper in Immnunity has been retracted after two separate panels determined some of the figures “inappropriately presented” the data but cleared the team of wrongdoing.
However, the original data are now unavailable, according to the notice, so there’s no way to know if the paper’s conclusions are sound.
A 2012 expression of concern prompted by an authorship dispute has been upgraded to a retraction.
As we reported in 2012, Revista Brasiliera de Reumatologia (aka the Brazilian Journal of Rheumatology) issued an expression of concern about “Anticitrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection” after
a claim from one of the authors, questioning the authorship of the corresponding author, and informed that the article was under submission to another journal.
A University of Calgary diabetes researcher, Cory Toth, who told us earlier this year that he would cease publishing in the scientific literature, has two more retractions, making seven.